Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05186116 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

LDLT in Non Resectable Colo-rectal Cancer Liver Metastasis

Study acronym: LIVERMORE
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Eligibility criteria shortened, about 10 wordsv4
  2. Interventions: Living donor liver transplant (Procedure) to Living donor liver transplant, Split liver transplant, RAPID, DDLT (Procedure)v3
  3. Re-verified, no change to tracked fieldsv2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is an interventional open label prospective study that aims to assess both overall and disease-free survival of patients treated with LDLT, partial or whole graft LT from deceased donors for unresectable CRLM. Secondary outcomes are graft survival and donor outcomes in terms of safety and quality of life. Donor selection is performed according to the currently used Institutional and National standards and protocols.
Trial Details
NCT Number NCT05186116
Lead Sponsor Azienda Ospedaliero-Universitaria di Modena
Conditions
(from sponsor)		 Colon Adenocarcinoma, Liver Metastasis Colon Cancer
Related terms Colonic Neoplasms
Enrollment 25 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov